Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 22, 2018
Pharmacy Choice - News - Front Page Healthcare News - February 22, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

2/22/18 - Active Substance Dexamethasone Intravitreales Implant, [TendersInfo (India)]
Contract notice: active substance dexamethasone intravitreales implant,. the dak-g assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory accessibility of all pharmaceutical companies. Prerequisites for the conclusion or subsequent accession to the contract
2/22/18 - FDAnews Announces New Direct Marking Requirements for UDIs: How to Comply with the Final Guidance Webinar, March 6, 2018
The FDA has handed devicemakers a high-stakes puzzle:. It'd be great to find out what the FDA was actually thinking when it put together that final guidance. Jay Crowley, a 27- year veteran of the FDA, was patient safety advisor to the CDRH until 2014, when he joined the regulatory consulting firm USDM Life Sciences as vice president of its unique
2/22/18 - Global Durable Medical Equipment (DME) Market Expected to Represent a Value of US $228.65 Mn by 2025: The global durable medical equipment market was valued at US$112.30 mn in 2016 and is expected to reach US$228.65 mn by the end of 2025. During the
Albany, NY 02/21/2018 New research report offers a comprehensive analysis of the " Durable Medical Equipment Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017- 2025" The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Requ
2/22/18 - Here's how much overdoses are costing South Carolina hospitals and you [The Island Packet (Hilton Head Island, S.C.)]
Feb. 21 The opioid epidemic in South Carolina isn't just hurting those who overdose, it's putting a serious toll on hospitals and other patients as well. In 2016, total overdose admissions and emergency department visits cost South Carolina hospitals an estimated $58.6 million, according to a report from the Medical University of South Carolina.
2/22/18 - Medical Device Connectivity Market Dynamics, Segments and Supply Demand 2018-2025: The report Medical Device Connectivity market determines the detail price, market share and the growth rate of top manufacturers which is depend on the various segment
New York, NY 02/21/2018 The latest industry intelligence research on the Medical Device Connectivity market offers a repository of valuable data on the size, share, and growth rate of the Medical Device Connectivity market for the forecast period, 2018- 2025. Importantly, examination of various facets of the industry including but not limited
2/22/18 - Medical Imaging Reagents Market Trends & Projection to : Rapid development across a number of technology fields promise to change the medical imaging industry by enabling novel imaging reagents and unique market opportunities.
Albany, NY 02/21/2018 Medical imaging is used to define the use of conventional and sophisticated diagnostic practices. Traditional imaging techniques like computed tomography, magnetic resonance imaging, ultrasound, X-ray, and nuclear medicine usually analyze morphology and anatomy but are unable to detect changes at the molecular level.
2/22/18 - Tandem Diabetes Care Applies for Medical Device License in Canada
2018 is shaping up to be an exciting year for Tandem Diabetes Care thanks to its application made to Health Canada announced on Tuesday.. This diabetes care focused company is the only to manufacture an insulin pump with a touchscreen and is now hoping to break into the Canadian diabetes market with a Health Canada medical device license. This a
2/22/18 - What is Medical Device Security?
Global healthcare cybersecurity is anticipated to spend more than $65 billion to 2021, and ransomware attacks on healthcare organizations are predicted to quadruple by 2020, according to a Cybersecurity Ventures report, noting that hospitals are most at risk. In 2017, 21st Century Oncology agreed to pay a $2.3 million fine on December 12, 2017 to t
2/21/18 - "System and Method for Monitoring Pharmaceutical Usage" in Patent Application Approval Process (USPTO 20180032699)
By a News Reporter-Staff News Editor at Telecommunications Weekly A patent application by the inventors Carrender, Curtis L.; Morrisey, Daniel; Sainion, Soneer, filed on July 28, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent applicati
2/21/18 - AbbVie and Voyager Therapeutics Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer's disease
NORTH CHICAGO- AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and..
2/21/18 - AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies [Algeria Press Service]
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer`s disease and other...
2/21/18 - AbbVie Announces Positive Topline Results from Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids
AbbVie, a global research and development-based biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc., announced that the Phase 3 ELARIS UF-I study of elagolix met its primary endpoint. Uterine fibroids are the most common type of abnormal growth in a woman's pelvis and can affect up to 80 percent of women by age 50. 1 Fibro
2/21/18 - AbbVie Presents New Positive Late-Breaking Data from Two Phase 3 Psoriasis Trials of Risankizumab at the 2018 American Academy of Dermatology Annual Meeting
AbbVie presented new positive results from clinical trials that evaluated risankizumab compared to placebo or ustekinumab, at the 2018 American Academy of Dermatology Annual Meeting in San Diego.
2/21/18 - AbbVie, Voyager Launch Up-to-$1.1B+ Gene-Therapy Collaboration to Treat Alzheimer`s, Neurodegenerative Diseases [T-break Tech (Middle East)]
AbbVie will partner with Voyager Therapeutics to develop and commercialize gene therapies for Alzheimer`s disease and other neurodegenerative diseases, through a collaboration that could generate more than $1.1 billion- plus for Voyager, the companies said today. Voyager`s vectorized antibody platform presents an innovative approach to addressing..
2/21/18 - AbilityPharma Announces FDA Approval of Phase 1/2 Trial of ABTL0812 for Patients with Advanced Metastatic Pancreatic Cancer
BARCELONA, Catalonia, Spain- Ability Pharmaceuticals SL, a biopharmaceutical company announced today that the United States Food and Drug Administration has approved a phase 1/ 2 study to assess the efficacy and safety of ABTL0812 in combination with gemcitabine and nab-paclitaxel in patients with advanced metastatic pancreatic cancer at first line
2/21/18 - Achieve Announces Preliminary Data from Cytisine Phase I II Multi-Dose Pharmacokinetic and Pharmacodynamics Clinical Study
BOTHELL, Washington and VANCOUVER- Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced preliminary data from their Phase I/II multi-dose, pharmacokinetic and pharmacodynamics clinical study of cytisine.
2/21/18 - Affinity Health Plan Names Scott Breidbart, M.D., M.B.A., as Chief Medical Officer
Dr. Breidbart is an accomplished managed care executive with over 20 years of experience driving quality improvement and establishing quality-based payment models. Most recently, Dr. Breidbart was the Chief Medical Officer at Solera Health in Phoenix, Arizona, where he was instrumental in strengthening the partnership between the company s healt
2/21/18 - AHA Issues Statement on Proposed Short-Term Health Insurance Plans
The American Hospital Association issued the following statement by President and CEO Rick Pollack on proposed short-term health insurance plans:. "Patients and families depend on health insurance to access and be able to afford the care they need when they need it. Today's proposed rule is a step in the wrong direction for patients and health car
2/21/18 - Aimmune shares surge as PhIII peanut allergy study wows on the primary endpoint, setting up FDA pitch [Sport360]
Four months after DBV Technologies stock was crushed by a shaky set of pivotal data for its peanut allergy drug, rival Aimmune Therapeutics$ AIMT says its Phase III has come through with a promising set of results. And the win sets up an FDA application later this year for the pioneering drug, with a European pitch to follow soon after. Its great t
2/21/18 - Aldeyra Therapeutics Selected for Podium Presentation of Phase 2a Dry Eye Disease Results at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Aldeyra Therapeutics, Inc., a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with inflammatory diseases, today announced that the results of the Phase 2 a clinical trial of topical ocular reproxalap in dry eye disease were selected for podium presentation at the 2018 Association for Rese
2/21/18 - AMRI Appoints Anthony L. Mattacchione to Senior Vice President and Chief Financial Officer
Mr. Mattacchione succeeds Felicia Ladin, who announced her intention to leave AMRI in December 2017. Mr. Mattacchione has more than 30 years of experience in financial leadership positions with high growth companies across the life sciences tools, biopharmaceutical, chemicals and technology sectors. Before joining AMRI, Mr. Mattacchione spent five
2/21/18 - Amunix announces XTEN and ProTIA technology licensing agreement with Celgene [Mubasher (Saudi Arabia)]
-Amunix Operating Inc., a biopharmaceutical company focused on the discovery and development of novel immuno-oncology therapeutics, is pleased to announce that it has entered into a licensing agreement with Celgene. The agreement allows for the utilization of Amunixs proprietary XTEN and ProTIA technology to augment ongoing discovery and developmen
2/21/18 - ANTHEM, INC. - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
References in this Annual Report on Form 10- K to the terms "we," "our," "us," "Anthem" or the "Company" refer to Anthem, Inc., an Indiana corporation, and, unless the context otherwise requires, its direct and indirect subsidiaries. References to the term "states" include the District of Columbia, unless the context otherwise requires. Our Governm
2/21/18 - Antigen Kit Market Development Trends and Competitive Analysis 2025
Albany, NY 02/21/2018 Antigens are used for the production of antibodies. These can be toxins or other substances, which induce an immune response in the body. The global Antigen Kit Market is expected to grow in the near future owing to increasing demand for antigen kit in various application segments such as rapid medical diagnostics, in vi
2/21/18 - AstraZeneca - US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415